MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/01.ccm.0000079610.88771.62

Медицинская библиотека · Critical care medicine · 2003

Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.

Dworschak Martin, Franz Maximilian, Czerny Martin, Gorlitzer Michael, Blaschek Marieluise, Grubhofer Georg, Haider Wolfram

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Repeated induction of ventricular fibrillation with ensuing alterations in electroencephalogram and jugular venous oxygen saturation is common practice during insertion of transvenous implantable cardioverters/defibrillators. We investigated whether these functional changes are also associated with cerebral injury.

DESIGN

Prospective study.

SETTING

University hospital.

PATIENTS: We studied 45 patients undergoing implantable cardioverter/defibrillator insertion. Eleven patients with cardiac pacemaker implantation, which was performed in the same manner yet without the necessity to induce ventricular fibrillation, served as controls.

MEASUREMENTS AND MAIN

RESULTS

Serum neuron-specific enolase and S100 were determined before, immediately postoperatively, and 2 hrs postoperatively. In a randomly composed subgroup, neuron-specific enolase was also determined 6 and 24 hrs after surgery. Implantable cardioverter/defibrillator patients only showed an increase of both markers postoperatively. Median neuron-specific enolase values climbed from a preoperative 9.9 to 12.3 and 14.4 microg/L at 2 and 24 hrs after surgery, respectively. This increase was associated with the number of shocks and the cumulative time in circulatory arrest. The highest median S100 level (0.075 microg/L) was reached 2 hrs after the procedure. Neuron-specific enolase and S100 were extremely elevated (13.7 and 0.970 microg/L, respectively) in one patient after an extended episode of ventricular fibrillation. Plasma hemoglobin levels were in the normal range in implantable cardioverter/defibrillator patients throughout the observation period.

CONCLUSIONS

Apparently, even brief successive periods of global cerebral ischemia cause neuronal damage without obvious severe neurologic deficits. However, they may be related to subtle postoperative neurologic or cognitive dysfunctions that a number of implantable cardioverter/defibrillator patients exhibit after implantation.

Для цитирования: Dworschak Martin, Franz Maximilian, Czerny Martin, Gorlitzer Michael, Blaschek Marieluise, Grubhofer Georg, Haider Wolfram. Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.. Critical care medicine. 2003. DOI: 10.1097/01.ccm.0000079610.88771.62.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.